Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases. The Program Lead will be responsible for the successful development of Telix renal cancer imaging products (up to and including Phase 3 clinical trials). The role will be responsible for creating, implementing, managing and executing the drug development plan. The successful delivery of the development plan will require leading a cross-functional team including manufacturing, non-clinical, clinical, quality and regulatory and a strong understanding of oncology drug development. This role is critical to the further development and successful delivery of Telix’s product portfolio by driving the current and future development of this newly acquired product.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Education Level
Bachelor's degree
Number of Employees
251-500 employees